RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SFN | Stratifin | Cancer-related genes Plasma proteins
| | | | | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | | | | Group enriched |
TGM1 | Transglutaminase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
UPK1A | Uroplakin 1A | Predicted membrane proteins
| | | | | Group enriched |
BTBD11 | BTB (POZ) domain containing 11 | | | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CRABP2 | Cellular retinoic acid binding protein 2 | | | | | | Tissue enriched |
ERO1L | ERO1-like (S. cerevisiae) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT78 | Keratin 78 | Plasma proteins
| | | | | Tissue enriched |
SERPINB5 | Serpin peptidase inhibitor, clade B (ovalbumin), member 5 | Plasma proteins
| | | | | Group enriched |
AIM1L | Absent in melanoma 1-like | | | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ARNTL2 | Aryl hydrocarbon receptor nuclear translocator-like 2 | Transcription factors
| | | | | Tissue enhanced |
BARX2 | BARX homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
C1orf110 | Chromosome 1 open reading frame 110 | | | | | | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | | | | | | Tissue enhanced |
C6orf132 | Chromosome 6 open reading frame 132 | | | | | | Tissue enhanced |
CD1A | CD1a molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CHAC1 | ChaC, cation transport regulator homolog 1 (E. coli) | | | | | | Tissue enhanced |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DSC2 | Desmocollin 2 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ENDOU | Endonuclease, polyU-specific | Predicted secreted proteins
| | | | | Tissue enhanced |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
ESPL1 | Extra spindle pole bodies homolog 1 (S. cerevisiae) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FZD10 | Frizzled family receptor 10 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRHL1 | Grainyhead-like 1 (Drosophila) | Transcription factors
| | | | | Tissue enhanced |
GSDMC | Gasdermin C | | | | | | Tissue enhanced |
HES2 | Hes family bHLH transcription factor 2 | Transcription factors
| | | | | Tissue enhanced |
HIST1H2BF | Histone cluster 1, H2bf | Plasma proteins
| | | | | Tissue enhanced |
IL1RN | Interleukin 1 receptor antagonist | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IVL | Involucrin | Plasma proteins
| | | | | Tissue enhanced |
KLK10 | Kallikrein-related peptidase 10 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK7 | Kallikrein-related peptidase 7 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KRT24 | Keratin 24 | Plasma proteins
| | | | | Tissue enhanced |
MYH8 | Myosin, heavy chain 8, skeletal muscle, perinatal | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
NIPAL1 | NIPA-like domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
NKX6-1 | NK6 homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
PKP3 | Plakophilin 3 | Plasma proteins
| | | | | Tissue enhanced |
PPL | Periplakin | Cytoskeleton related proteins Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
PTK6 | Protein tyrosine kinase 6 | Enzymes
| | | | | Tissue enhanced |
RIPK4 | Receptor-interacting serine-threonine kinase 4 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
RNASE7 | Ribonuclease, RNase A family, 7 | Predicted secreted proteins
| | | | | Tissue enhanced |